Strain SummaryC3H/HeN
Strain Name |
C3H/HeN |
Strain Type(s) |
inbred |
Strain Synonym(s) |
C3H • C3H/HeN-Mtv+ • C3H/HeN(MMTV-) • C3H/HeN- |
Strain Links |
• Festing's List of Inbred Strains |
| Frequency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
| Forestomach hyperplasia | Forestomach | N-methyl-N-nitrosourea (MNU) |
30 |
References: Masui T, Cancer Lett 1997 Jan 1;111(1-2):97-104 |
||||
| Forestomach papilloma | Forestomach | N-methyl-N-nitrosourea (MNU) |
40 |
References: Masui T, Cancer Lett 1997 Jan 1;111(1-2):97-104 |
||||
| Forestomach squamous cell carcinoma - well differentiated | Forestomach | N-methyl-N-nitrosourea (MNU) |
20 |
References: Masui T, Cancer Lett 1997 Jan 1;111(1-2):97-104 |
||||
| Intestine metaplasia | Intestine | N-methyl-N-nitrosourea (MNU) |
0 |
References: Yamamoto M, Jpn J Cancer Res 1997 Mar;88(3):238-44 |
||||
| Liver hepatocellular carcinoma | Liver |
41 |
References: Staats J, Cancer Res 1985 Mar;45(3):945-77 |
|||||
| Lung adenoma | Lung | urethane (ethyl carbamate) |
36 |
References: Malkinson AM, J Natl Cancer Inst 1983 May;70(5):931-6 |
||||
| Mammary gland adenocarcinoma | Mammary gland |
observed |
References: Mikaelian I, Personal Communication 2003;(): 2 pathology image(s) |
|||||
| Mammary gland adenocarcinoma | Mammary gland | diethylstilbestrol (DES) |
14 |
References: Bennett LM, Cancer Res 2000 Jul 1;60(13):3461-9 |
||||
| Mammary gland adenocarcinoma - papillary/cystic | Mammary gland | diethylstilbestrol (DES) |
7.1 |
References: Bennett LM, Cancer Res 2000 Jul 1;60(13):3461-9 |
||||
| Mammary gland tumor | Mammary gland | diethylstilbestrol (DES) |
14 |
References: Bennett LM, Cancer Res 2000 Jul 1;60(13):3461-9 |
||||
| Mammary gland tumor | Mammary gland | MMTV - mouse mammary tumor virus |
observed |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |
||||
| Myoepithelial cell myoepithelioma | Salivary gland - Parotid |
observed |
References: Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
|||||
| Renal pelvis carcinoma | Renal pelvis | N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) |
50 |
References: Yamamoto S, Carcinogenesis 1998 May;19(5):855-60 |
||||
| Stomach - Glandular - Pyloric antrum adenocarcinoma | Stomach - Glandular - Pyloric antrum | N-methyl-N-nitrosourea (MNU) |
0 - 60 |
References: Yamamoto M, Jpn J Cancer Res 1997 Mar;88(3):238-44 |
||||
| Stomach - Glandular - Pyloric antrum hyperplasia - adenomatous | Stomach - Glandular - Pyloric antrum | N-methyl-N-nitrosourea (MNU) |
0 - 100 |
References: Yamamoto M, Jpn J Cancer Res 1997 Mar;88(3):238-44 |
||||
| Stomach - Glandular - Pyloric antrum hyperplasia - adenomatous | Stomach - Glandular - Pyloric antrum |
0 |
References: Yamamoto M, Jpn J Cancer Res 1997 Mar;88(3):238-44 |
|||||
| Stomach - Glandular - Pyloric antrum tumor | Stomach - Glandular - Pyloric antrum |
0 |
References: Yamamoto M, Jpn J Cancer Res 1997 Mar;88(3):238-44 |
|||||
| Stomach - Glandular adenocarcinoma | Stomach - Glandular | N-methyl-N-nitrosourea (MNU) |
10 |
References: Masui T, Cancer Lett 1997 Jan 1;111(1-2):97-104 |
||||
| Ureter carcinoma | Ureter | N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) |
0 |
References: Yamamoto S, Carcinogenesis 1998 May;19(5):855-60 |
||||
| Urinary bladder carcinoma | Urinary bladder | N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) |
90 |
References: Yamamoto S, Carcinogenesis 1998 May;19(5):855-60 |
||||
| Urinary bladder carcinoma in situ | Urinary bladder |
0 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
|||||
| Urinary bladder carcinoma in situ | Urinary bladder | N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) |
37.5 - 47 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
||||
| Urinary bladder dysplasia | Urinary bladder |
22 |
0 - 9.1 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
||||
| Urinary bladder dysplasia | Urinary bladder | N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) |
65 - 75 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
||||
| Urinary bladder dysplasia | Urinary bladder | N-methyl-N-nitrosourea (MNU) ⋅ ZnSO4 |
40 - 75 |
29 - 100 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
|||
| Urinary bladder squamous cell carcinoma | Urinary bladder |
0 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
|||||
| Urinary bladder squamous cell carcinoma | Urinary bladder | N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) |
0 - 44 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder |
0 |
0 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder | N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) |
0 - 62.5 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder | N-methyl-N-nitrosourea (MNU) ⋅ ZnSO4 |
0 - 25 |
References: Chen T, Teratog Carcinog Mutagen 1998;18(3):101-10 |
||||
| Uterus adenocarcinoma | Uterus |
0 |
References: Bennett LM, Cancer Res 2000 Jul 1;60(13):3461-9 |
|||||
| Uterus adenocarcinoma | Uterus | diethylstilbestrol (DES) |
50 |
References: Bennett LM, Cancer Res 2000 Jul 1;60(13):3461-9 |
||||
| (Unspecified organ) squamous cell carcinoma | (Unspecified organ) |
0 |
References: Bennett LM, Cancer Res 2000 Jul 1;60(13):3461-9 |
|||||
| (Unspecified organ) squamous cell carcinoma | (Unspecified organ) | diethylstilbestrol (DES) |
7.1 |
References: Bennett LM, Cancer Res 2000 Jul 1;60(13):3461-9 |
||||